Ruivo, A.; Oliveira, R.C.; Silva-Vaz, P.; Tralhão, J.G. Colorectal Cancer Liver Metastasis—State-of-the-Art and Future Perspectives. Gastrointest. Disord.2023, 5, 580-608.
Ruivo, A.; Oliveira, R.C.; Silva-Vaz, P.; Tralhão, J.G. Colorectal Cancer Liver Metastasis—State-of-the-Art and Future Perspectives. Gastrointest. Disord. 2023, 5, 580-608.
Ruivo, A.; Oliveira, R.C.; Silva-Vaz, P.; Tralhão, J.G. Colorectal Cancer Liver Metastasis—State-of-the-Art and Future Perspectives. Gastrointest. Disord.2023, 5, 580-608.
Ruivo, A.; Oliveira, R.C.; Silva-Vaz, P.; Tralhão, J.G. Colorectal Cancer Liver Metastasis—State-of-the-Art and Future Perspectives. Gastrointest. Disord. 2023, 5, 580-608.
Abstract
The current management of colorectal cancer liver metastasis (CRCLM) patients involves a multidisciplinary approach with surgical resection remaining the primary curative option. The advances in liver surgery have improved outcomes, enabling more patients to undergo surgery successfully. In addition, the development of imaging software has improved the preoperative planning and patient selection for surgery and other interventions. Systemic therapies, such as targeted therapies and immunotherapies have enhanced the chances of complete resection. Targeted agents in combination with chemotherapy, have shown efficacy in downstaging tumors and increasing resectability.
Keywords
Colon cancer; metastasis; Liver Neoplasms; Review Literature
Subject
Medicine and Pharmacology, Oncology and Oncogenics
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
